Leap Therapeutics, Inc. (LPTX) Dividend History

Leap Therapeutics, Inc. (LPTX) is a biotechnology company focused on developing innovative immuno-oncology therapies. The company aims to create targeted treatments that enhance the body's immune response against cancer by identifying and developing novel biologic agents. Based in the United States, Leap Therapeutics is engaged in advancing therapies through research and clinical trials to address unmet needs in cancer treatment.

47 Thorndike Street, Cambridge, MA, 02142
Phone: 617 252 4343
Website:

Dividend History

Leap Therapeutics, Inc. currently does not pay dividends

Company News

  • The metastatic colorectal cancer pipeline is rapidly expanding, with over 150 pharmaceutical companies developing 180+ pipeline drugs. Novel therapies, including small molecules, antibodies, and tumor microenvironment modulators, are gaining traction and could reshape the treatment landscape.

    GlobeNewswire Inc.
    Featured Companies: EXEL REPL
  • Leap Therapeutics (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

    Zacks Investment Research
  • Shares of FLJ Group Limited (NASDAQ: FLJ) shares jumped during Friday’s session after the company announced it entered into a definitive agreement to acquire Alpha Mind Technology. FLJ Group shares jumped 96.4% to $0.2123 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Versus Systems Inc. (NASDAQ: VS) shares jumped 129.8% to $0.3816. Versus Systems announced a strategic investment from Cronus Equity Capital Group, LLC. BioNexus Gene Lab Corp. (NASDAQ: BGLC) jumped 78% to $0.6596. Quhuo Limited (NASDAQ: QH) gained 34% to $1.57. iRobot Corporation (NASDAQ: IRBT) gained 28.7% to $38.32. Amazon.com Inc.’s (NASDAQ: AMZN) proposed acquisition of iRobot is reportedly on the verge of receiving unconditional approval from European Union antitrust authorities. iClick Interactive Asia Group Limited (NASDAQ: ICLK) climbed 25.7% to $3.77 after the company penned a merger deal with TSH Investment Holding and TSH Merger Sub Limited. Captivision Inc. (NASDAQ: CAPT) gained 24% to $2.01. Scilex Holding Company (NASDAQ: SCLX) climbed 22.7% to $1.24. MMTec, Inc. (NASDAQ: MTC) shares climbed 19.3% to $1.17. The company recently reported a narrower loss for H1. Gyre Therapeutics, Inc. ...

    Benzinga
  • Raymond James has decided to maintain its Outperform rating of Leap Therapeutics (NASDAQ:LPTX) and lower its price target from $18.50 to $17.50. Shares of Leap Therapeutics are trading up 4.9% over the last 24 hours, at $1.50 per share. A move to $17.50 would account for a 1066.67% increase from the current share price. About Leap Therapeutics Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that ...Full story available on Benzinga.com

    Benzinga
  • Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq. Hoth Therapeutics, Inc. (NASDAQ: HOTH) rose 96% to $3.6850 after the company announced preclinical results for HT-ALZ for the treatment of Alzheimer's disease. Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 37.8% to $0.5928. Zura Bio Limited (NASDAQ: ZURA) shares gained 25% to $8.11 after the company completed approximately $80 million financing with the focus on advancing ZB-106, a potential first-in-class anti-IL-17 and anti-BAFF dual antagonist. Xunlei Limited (NASDAQ: XNET) rose 22% to $1.6715. Xunlei launched a $20 million share buyback program. G-III Apparel Group, Ltd. (NASDAQ: GIII) gained 21.7% to $20.13 following first-quarter results. G-III Apparel reported a master licensing partnership with Xcel Brands to design and produce all categories and distribute products globally for the Halston business and all of its brands. GT Biopharma, Inc. (NASDAQ: GTBP) rose 20.7% to $0.35. Secoo Holding Limited (NASDAQ: SECO) gained 20.2% to $0.9739. GitLab Inc. (NASDAQ: GTLB) shares climbed 19.9% to $42.43 after the company reported better-than-expected first-quarter results. Multiple analysts raised their price targets on the stock following the report. Big Lots, Inc. (NYSE: BIG) gained 18.1% to $6.97. Chijet Motor Company, Inc. (NASDAQ: TTOO) shares surged 18.1% to $0.0827after dipping around 31% on Monday. T2 Biosystems reported submission for the FDA breakthrough device designation for candida auris diagnostic test. Castle Biosciences, Inc. (NASDAQ: CSTL) gained 18.8% to $13.86. Canaccord Genuity maintained Castle Biosciences with a Buy and lowered the price target from $60 to $40. Novo ...

    Benzinga
Dividend data last updated 06/07/2025 20:15:44 UTC